ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
SPDR S&P Biotech ETF
154.03
-3.5700
-2.27%
盤前:
154.48
0.4500
+0.29%
04:43 EDT
成交量:
1,130.06萬
成交額:
17.39億
市值:
105.01億
市盈率:
8.45
高:
157.53
開:
157.08
低:
152.63
收:
157.60
52周最高:
169.89
52周最低:
93.26
股本:
6,817.50萬
流通股本:
6,817.50萬
量比:
1.47
換手率:
16.58%
股息:
0.57
股息率:
0.37%
每股收益(TTM):
18.23
淨資產收益率:
--
總資產收益率:
--
市淨率:
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
龔正會見美國賽默飛世爾科技董事長,希望公司深度融入上海生物醫藥產業生態
智通财经
·
08/19
曾輝:銀河通用在文旅消費、工業製造、醫療健康等領域實現規模商用
睿见Economy
·
08/19
醫療板塊市場快訊匯總:多家機構研判行業動向
投资观察
·
08/19
全民醫療保障「十五五」規劃:大力推動商業醫療保險發展
智通财经
·
08/19
全民醫療保障「十五五」規劃:大力推動商業醫療保險發展
智通财经
·
08/19
國家醫保局:大力推動商業醫療保險發展
金吾财讯
·
08/19
《全民醫療保障「十五五」規劃》發布
金吾财讯
·
08/19
國家醫保局:大力推動商業醫療保險發展
格隆汇
·
08/19
國家醫保局:提高基金抗風險能力和使用效率,到2029年基本實現省級統籌
格隆汇
·
08/19
《全民醫療保障「十五五」規劃》發布
格隆汇
·
08/19
上海張江高新技術產業開發區發展「十五五」規劃:增強生物醫藥全鏈條創新能力
格隆汇
·
08/19
中國駐韓國大使戴兵:在人工智能、高端製造、生物醫藥、綠色低碳、銀髮經濟等領域探索合作
智通财经
·
08/19
險資加速進軍S基金:上半年出資佔比由3%躍升至41%
中国经营报
·
08/19
醫療健康板塊市場動態綜述
投资观察
·
08/19
突破2500億元能級:蘇州「藥」業做對了什麼
经济参考报
·
08/19
醫療保健板塊市場快訊匯總
投资观察
·
08/19
石家莊錨定五大產業賽道 推動經濟高質量發展
滚动播报
·
08/18
醫療健康板塊市場快訊綜述
投资观察
·
08/18
港股收評:恒指漲0.07% 科指跌0.9% 芯片股走弱 生物醫藥板塊活躍
新浪港股
·
08/18
北汽副總史志山年薪75.41萬元 連續兩年低於同期上任的副總胡漢軍
运营商财经网
·
08/18
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/XBI/news?page=8"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"XBI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","market":"US","secType":"STK","nameCN":"SPDR S&P Biotech ETF","latestPrice":154.03,"timestamp":1789502400000,"preClose":157.6,"halted":0,"volume":11300561,"hourTrading":{"tag":"盘前","latestPrice":154.48,"preClose":154.03,"latestTime":"04:43 EDT","volume":1341,"amount":207358.23996,"timestamp":1789548206980,"change":0.45,"changeRate":0.002922,"amplitude":0.005363},"delay":0,"changeRate":-0.02265228426395935,"floatShares":68175000,"shares":68175000,"eps":18.23,"marketStatus":"盤前交易","change":-3.57,"latestTime":"09-16 05:33:47 EDT","open":157.08,"high":157.53,"low":152.63,"amount":1738536841.14598,"amplitude":0.031091,"askPrice":154.8,"askSize":400,"bidPrice":154,"bidSize":400,"shortable":3,"etf":1,"ttmEps":18.23,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1789565400000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":154.03,"sharesOutstanding":63325000,"nav":157.586874,"aum":10743485169.21,"dividendRate":0.0037,"bidAskSpread":0.000306,"preHourTrading":{"tag":"盘前","latestPrice":154.48,"preClose":154.03,"latestTime":"04:43 EDT","volume":1341,"amount":207358.23996,"timestamp":1789548206980,"change":0.45,"changeRate":0.002922,"amplitude":0.005363},"postHourTrading":{"tag":"盘后","latestPrice":154.1,"preClose":154.03,"latestTime":"19:59 EDT","volume":217310,"amount":33483251.403,"timestamp":1789516796776,"change":0.07,"changeRate":0.000454,"amplitude":0.001883},"volumeRatio":1.4749354161726091,"optionData":{"bulkOrders":[{"symbol":"XBI","call":false,"expireDate":1792123200000,"strike":"150.0","timestamp":1789502340274,"price":3.85,"volume":15000,"amount":5775000,"type":"+"},{"symbol":"XBI","call":false,"expireDate":1789704000000,"strike":"158.0","timestamp":1789502340274,"price":4.52,"volume":15000,"amount":6780000,"type":"-"}]},"impliedVol":0.319,"impliedVolPercentile":0.62},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","floatShares":68175000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.4749354161726091,"shares":68175000,"dividePrice":0.5699,"high":157.53,"amplitude":0.031091,"preClose":157.6,"low":152.63,"week52Low":93.26,"pbRate":"--","week52High":169.89,"institutionHeld":0.8511,"latestPrice":154.03,"eps":18.23,"divideRate":0.0037,"volume":11300561,"delay":0,"ttmEps":18.23,"open":157.08,"prevYearClose":121.93,"prevWeekClose":156.2,"prevMonthClose":162.5,"prevQuarterClose":158.25,"fiveDayClose":161.93,"twentyDayClose":159.53,"sixtyDayClose":140.72},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XBI\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"XBI","amount":0.138094,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-24","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-24"},{"date":"2025-12-22","symbol":"XBI","amount":0.406564,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-24"},{"date":"2025-09-22","symbol":"XBI","amount":0.02665,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-24"},{"date":"2025-06-23","symbol":"XBI","amount":0.007295,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-25","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-25"},{"date":"2025-03-24","symbol":"XBI","amount":0.00525,"announcedDate":"2025-03-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-24","defaultRemindTime":1742823000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-26","payableDate":"2025-03-24","currency":"USD","dateTimestamp":1742788800000,"payDate":"2025-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XBI\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-26","value":0.031139,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-27","value":0.01831,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-27","value":0.019702,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-26","value":0.110135,"currency":"USD"},{"executeDate":"2017-09-15","recordDate":"2017-09-18","paymentDate":"2017-09-25","value":0.03704,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XBI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XBI\",pageSize:20,pageCount:8,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660447650","title":"龔正會見美國賽默飛世爾科技董事長,希望公司深度融入上海生物醫藥產業生態","url":"https://stock-news.laohu8.com/highlight/detail?id=2660447650","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660447650?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 19:07","pubTimestamp":1787137652,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4548","IE00B19Z8W00.USD","LU1989771016.USD","XBI","LU0557290698.USD","BK4121","LU0320765489.SGD","LU1291159041.SGD","LU1057294990.SGD","LU0528227936.USD","IE00BQXX3F31.USD","IE00BFTCPJ56.SGD","TMO","FMED","LU2125910336.SGD","LU1633808545.USD","HRTS","LU1280957306.USD","GB00BDT5M118.USD","LU0208291251.USD","IE0034235188.USD","LU0266013472.USD","LU1670627923.USD","LU1983299246.USD","LU0957791311.USD","LU1988902786.USD","TMED","LU1623119135.USD","IE00BJT1NW94.SGD","LU0882574055.USD","LU0061474960.USD","LU0122379950.USD","LU1803068623.USD","LU1923621640.USD","LU2125909593.SGD","LU2092937221.SGD","LU0432979614.USD","LU2357305700.SGD","GNMX","IE00B1BXHZ80.USD","LU0310800379.SGD","LU1720051017.SGD","LU1791710400.SGD","LU2063271972.USD","BK4533","BK4585","BK4588","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660449520","title":"曾輝:銀河通用在文旅消費、工業製造、醫療健康等領域實現規模商用","url":"https://stock-news.laohu8.com/highlight/detail?id=2660449520","media":"睿见Economy","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660449520?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 17:19","pubTimestamp":1787131140,"startTime":"0","endTime":"0","summary":"银河通用机器人高级副总裁曾辉出席“AI大模型赋能机器人与具身智能产业新范式交流活动”围绕打造人形机器人智能经济新生态展开分享。曾辉表示,银河通用积极响应国家关于打造智能经济新形态和实景实训的号召,在文旅消费、工业制造、医疗健康等领域实现规模商用。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/hy/hyjz/2026-08-19/doc-ininvwqs2631907.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["XBI","BK4550","IJK","BK4585","VOE","BK4581","VHT","XLV","LABU","REGL","159760","IXJ","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175089982","title":"醫療板塊市場快訊匯總:多家機構研判行業動向","url":"https://stock-news.laohu8.com/highlight/detail?id=1175089982","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175089982?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 16:26","pubTimestamp":1787127985,"startTime":"0","endTime":"0","summary":"0722 GMT——华侨银行集团研究分析师Troy Cheng在最新报告中指出,Foundation Healthcare已占据有利位置,有望把握从住院治疗向低成本门诊治疗转型的市场机遇。Foundation Healthcare旗下拥有四家医疗中心,不仅能够获取设施和诊断相关收入,还能更好地掌控患者的康复进程。作为新加坡规模最大、增长最快的多专科医疗平台之一,该公司获得华侨银行首次覆盖,给予买入评级,合理估值定价为1.13新加坡元。该股当前报0.755新加坡元,跌幅1.3%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","BK4581","BK4585","BK4588","LABU","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660448216","title":"全民醫療保障「十五五」規劃:大力推動商業醫療保險發展","url":"https://stock-news.laohu8.com/highlight/detail?id=2660448216","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660448216?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 15:33","pubTimestamp":1787124830,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LABU","XLV","BK4588","BK4585","XBI","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660044829","title":"全民醫療保障「十五五」規劃:大力推動商業醫療保險發展","url":"https://stock-news.laohu8.com/highlight/detail?id=2660044829","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660044829?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 15:33","pubTimestamp":1787124830,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,8月19日,国家医疗保障局发布关于印发《全民医疗保障“十五五”规划》的通知。其中提出,大力推动商业医疗保险发展。积极支持商业医疗保险在多层次医疗保障体系中更好发挥作用,提升服务保障水平。鼓励商保与基本医保衔接互补、差异化发展。聚焦群众多样化需求,支持商保丰富产品供给。在风险可控、经营可持续基础上,积极将医疗新技术、新服务、新药品、新器械应用纳入商保保障。依法依规推进基本医保与商保数据共享、同步结算,支持商保快赔直赔。原文如下:国家医疗保障局关于印发《全民医疗保障“十五五”规划》的通知本文编选自国家医疗保障局,智通财经编辑:陈雯芳。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1481886.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","LABU","XBI","BK4581","XLV","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660383414","title":"國家醫保局:大力推動商業醫療保險發展","url":"https://stock-news.laohu8.com/highlight/detail?id=2660383414","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660383414?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 12:41","pubTimestamp":1787114516,"startTime":"0","endTime":"0","summary":"金吾财讯 | 国家医保局解读《全民医疗保障“十五五”规划》。其中提出,大力推动商业医疗保险发展。积极支持引导商业医疗保险与基本医保衔接互补、差异化发展,聚焦群众多样化需求,支持商保公司丰富产品供给,重点支持发展以基本医保目录外责任为主、普惠程度高、支持医药创新发展等的商保产品,着力满足群众在基本医保之外的未被满足的保障需求,促进商业医疗保险在多层次医疗保障体系中更好发挥补充保障作用。","market":"sg","thumbnail":"https://static.szfiu.com/news/20241108/NzE1NDA5NTM3ODk1OQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/NzE1NDA5NTM3ODk1OQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1988704","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","BK4581","BK4588","LABU","BK4585","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660411091","title":"《全民醫療保障「十五五」規劃》發布","url":"https://stock-news.laohu8.com/highlight/detail?id=2660411091","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660411091?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 12:23","pubTimestamp":1787113383,"startTime":"0","endTime":"0","summary":"金吾财讯 | 据央视,国家医保局今天(19日)发布《全民医疗保障“十五五”规划》。“十五五”期间基本医疗保险参保率每年保持在95%左右;长期护理保险制度覆盖所有统筹地区;基本医疗保险目录内住院费用基金支付比例职工基本医疗保险稳定在80%左右,城乡居民基本医疗保险稳定在70%左右;即时结算基本医疗保险基金支出覆盖率从2025年的70%左右提高到80%以上;所有统筹地区将实现生育津贴直接发放到个人。","market":"fut","thumbnail":"https://static.szfiu.com/news/20241108/Y2Y0ZjIxMzUyMzg0MDEwNQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/Y2Y0ZjIxMzUyMzg0MDEwNQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1988693","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","BK4588","LABU","BK4585","XLV","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660411172","title":"國家醫保局:大力推動商業醫療保險發展","url":"https://stock-news.laohu8.com/highlight/detail?id=2660411172","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660411172?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 12:08","pubTimestamp":1787112519,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4588","BK4585","XBI","XLV","BK4581","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660411173","title":"國家醫保局:提高基金抗風險能力和使用效率,到2029年基本實現省級統籌","url":"https://stock-news.laohu8.com/highlight/detail?id=2660411173","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660411173?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 12:08","pubTimestamp":1787112495,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4588","XBI","BK4585","LABU","BK4581","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660411656","title":"《全民醫療保障「十五五」規劃》發布","url":"https://stock-news.laohu8.com/highlight/detail?id=2660411656","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660411656?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 11:54","pubTimestamp":1787111679,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LABU","BK4585","BK4588","XBI","XLV","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660791416","title":"上海張江高新技術產業開發區發展「十五五」規劃:增強生物醫藥全鏈條創新能力","url":"https://stock-news.laohu8.com/highlight/detail?id=2660791416","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660791416?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 10:26","pubTimestamp":1787106397,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4585","BK4588","399441","161726","BK4581","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660135724","title":"中國駐韓國大使戴兵:在人工智能、高端製造、生物醫藥、綠色低碳、銀髮經濟等領域探索合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2660135724","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660135724?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 08:41","pubTimestamp":1787100104,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["03034","AIFD","QTOC","MVPS","07522","SQQQ","QDEC","CWC","QID","WPAI","DQJN","PSQ","TARK","QQQX","ARTY","HLGE","NJAN","AIQU","QSWN","TECY","TQQQ","YUNG","AIBU","GK","QLD","PBOT","CPNQ","NBDS","LCLG","FWD","GPIQ","KOMP","NJUL","NEWZ","QMAR","CHAT","QQQ","LNGR","NOCT","QQA","QQQM","OGIG","TQQY","XBI","NAPR","AGIX","VUSE","AGNG","AQGX","MFIG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660490007","title":"險資加速進軍S基金:上半年出資佔比由3%躍升至41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660490007","media":"中国经营报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660490007?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 07:16","pubTimestamp":1787094976,"startTime":"0","endTime":"0","summary":"险资正通过不同策略深度参与S基金(私募股权二级市场基金)市场。另类资产投资信息平台执中(ZERONE)近期发布的《中国私募股权二级市场白皮书2026》(以下简称“白皮书”)显示,险资是金融机构S交易的压舱石,2025年交易规模达263亿元,约占当年金融机构买方总量的四分之三;今年上半年,在S交易市场整体交易规模收缩的情况下,险资出资规模虽有所收缩,但仍是金融机构中第一大买方。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608193845007377.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608193845007377.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4585","688825","BK4588","BK4581","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199762583","title":"醫療健康板塊市場動態綜述","url":"https://stock-news.laohu8.com/highlight/detail?id=1199762583","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199762583?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 04:53","pubTimestamp":1787086408,"startTime":"0","endTime":"0","summary":"聚焦医疗健康领域的最新市场快讯。这些内容仅在道琼斯通讯社于美东时间4:20、12:20及16:50独家发布。1931 GMT——澳大利亚制药企业CSL今日股价表现值得期待,RBC资本市场如是说。CSL的2026财年基础盈利和营收均超出市场预期。CSL预计2027财年营收将与2026财年持平,同时预期在剔除汇率波动影响后基础盈利将增长5%。这意味着基础净利润将达到29.3亿美元,高于市场普遍预期的28.3亿美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","BK4581","BK4585","XLV","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660494382","title":"突破2500億元能級:蘇州「藥」業做對了什麼","url":"https://stock-news.laohu8.com/highlight/detail?id=2660494382","media":"经济参考报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660494382?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 03:24","pubTimestamp":1787081097,"startTime":"0","endTime":"0","summary":"2026年8月,总部位于苏州的医药企业康宁杰瑞一纸公告引发关注——其与PathosAI就双抗ADC新药JSKN016达成授权协议,首付款1.25亿美元,交易潜在总金额超过22亿美元。不久前,信诺维科创板IPO尘埃落定,资本市场用一张宝贵的“入场券”,为这家苏州创新药企投下“信任票”。类似的BD(商务拓展)交易和IPO敲钟,正在2026年的苏州密集发生。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608193844968886.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608193844968886.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1574","XBI","LNGR","BK4581","BK4585","BK4588","IPOS","06978","BK1161","IBBQ","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120479003","title":"醫療保健板塊市場快訊匯總","url":"https://stock-news.laohu8.com/highlight/detail?id=1120479003","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120479003?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 00:23","pubTimestamp":1787070226,"startTime":"0","endTime":"0","summary":"医疗保健领域最新市场动态纷至沓来。这些快讯于美东时间4:20、12:20及16:50在道琼斯通讯社独家发布,为投资者带来行业前沿脉动。1931 ET——加拿大皇家银行资本市场认为,澳大利亚制药企业CSL的股价今日有望跑赢大盘。CSL预计2027财年营收将与2026财年持平,同时预期剔除汇率波动因素后基础盈利增长5%。这意味着基础净利润将达到29.3亿美元,高于市场共识预期的28.3亿美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4585","BK4588","XBI","XLV","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660746582","title":"石家莊錨定五大產業賽道 推動經濟高質量發展","url":"https://stock-news.laohu8.com/highlight/detail?id=2660746582","media":"滚动播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660746582?lang=zh_tw&edition=fundamental","pubTime":"2026-08-18 17:04","pubTimestamp":1787043840,"startTime":"0","endTime":"0","summary":"自2021年石家庄市第十一次党代会以来,这座城市锚定生物医药、新一代电子信息、先进装备制造、现代食品、现代商贸物流五大千亿级产业集群目标,坚持做优传统产业、做强主导产业、做大新兴产业,各项事业呈现出蓬勃发展的良好态势。近年来,石家庄深入实施创新驱动发展战略,全市拥有省级及以上科技创新平台500余家,总量位居全省第一。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-08-18/doc-ininttrp7303801.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4581","BK4585","BK4588","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161501594","title":"醫療健康板塊市場快訊綜述","url":"https://stock-news.laohu8.com/highlight/detail?id=1161501594","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161501594?lang=zh_tw&edition=fundamental","pubTime":"2026-08-18 16:25","pubTimestamp":1787041508,"startTime":"0","endTime":"0","summary":"野村还将这家印度制药公司的2027和2028财年销售额预估每年上调约2.5%。分析师表示,Ipca Laboratories的印度制剂销售预计将维持低双位数的增长百分比。该券商将股票目标价从1,725.00卢比上调至2,060.00卢比,维持买入评级不变。股价目前报1,881.05卢比,下跌0.1%。1020 GMT——摩根大通分析师表示,阿斯利康终止一项肺癌药物试验令人失望,但其他药物的积极数据可能推动市场共识销售指引上调。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","XLV","LABU","BK4581","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660857468","title":"港股收評:恒指漲0.07% 科指跌0.9% 芯片股走弱 生物醫藥板塊活躍","url":"https://stock-news.laohu8.com/highlight/detail?id=2660857468","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660857468?lang=zh_tw&edition=fundamental","pubTime":"2026-08-18 16:08","pubTimestamp":1787040480,"startTime":"0","endTime":"0","summary":"模拟交易客户端8月18日消息,港股三大指数涨跌不一。截至收盘,恒生指数涨0.07%,报25471.15,恒生科技指数跌0.9%,国企指数涨0.16%。猪肉股涨幅居前,牧原股份涨超4%。生物医药板块活跃,药明生物涨超4%。芯片股走弱,华虹宏力跌超7%。国金证券指出,AI正在推动半导体测试设备行业景气由传统周期修复转向结构成长。根据SEMI预测,全球半导体测试设备销售额预计于2026年同比增长31.0%至153亿美元,并于2028年达到208亿美元,2025-2028年复合增速约21%。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-08-18/doc-inintpiw0093013.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["03419","MHImain","BK4581","BK4588","HSImain","03037","MCHmain","BK4585","09115","02833","82800","BERZ","161726","07300","XBI","HSI","07200","03115","VXUS","399441","KCAI","HHImain","07500","513600","XSEM","02800","83115"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660468932","title":"北汽副總史志山年薪75.41萬元 連續兩年低於同期上任的副總胡漢軍","url":"https://stock-news.laohu8.com/highlight/detail?id=2660468932","media":"运营商财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660468932?lang=zh_tw&edition=fundamental","pubTime":"2026-08-18 16:08","pubTimestamp":1787040480,"startTime":"0","endTime":"0","summary":"运营商财经网 汽车频道王鑫垚/文近日,北汽集团公开高管2024年薪酬情况。数据显示,胡汉军在2024年拿到薪酬77.2万元,此外还有19.67万元的社会保险、企业年金、补充医疗保险及住房公积金的单位缴存部分。两方面合计达到96.87万元;史志山2024年薪酬为75.41万元,比胡汉军低了1.79万元。据了解,胡汉军和史志山都是在2023年上任北汽集团副总经理一职。当年,史志山的税前薪酬和综合隐性福利都不如胡汉军。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-08-18/doc-inintpin8658136.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LABU","BK4588","XBI","BK4581","BK4585","XLV"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":200,"code":"91000000","status":"200"}]}}